News analysis
Pfizer asked the Food and Drug Administration (FDA) on Nov. 16 to authorize its experimental antiviral pill for COVID-19.
Vials with Pfizer-BioNTech and Moderna COVID-19 vaccine labels in an illustration picture taken on March 19, 2021. Dado Ruvic/Illustration/Reuters
Samna Ghani
Freelance Reporter
|Updated:
Samna Ghani
Freelance Reporter
Samna Ghani covers health care business, management, and leadership. She has been a health care writer and editor for more than a decade.
Author’s Selected Articles
